Cerevance Inc.
- Address
- 1 Marina Park Drive Ste 1410
Sponsor Overview
Specializations
Neurodegenerative disorders
Research activity is centred on neurodegenerative disease, with attention to conditions involving progressive impairment of brain function and neuronal loss. The clinical focus includes therapeutic approaches aimed at modifying disease-related pathways in the central nervous system.
- Central nervous system therapeutics
- Neuroprotection
- Neurodegeneration
Interest extends to biologically targeted treatments for disorders that affect cognition, movement, and overall neurological integrity.
Healthy volunteer pharmacology
Clinical research also includes evaluation of investigational therapies in healthy volunteers, with emphasis on understanding safety and the way a compound is handled by the human body. This area supports early clinical assessment of drug exposure and systemic handling.
- Safety evaluation
- Human pharmacology
- Drug disposition
The work reflects a focus on foundational clinical questions relevant to advancing therapies for neurological conditions.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of the Safety and Pharmacokinetics of CVN293 in Healthy Volunteers for Neurodegenerative Disorders |  The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
1 centre- Address
- Zernikedreef 8, 2333 CL Leiden
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Cerevance Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.